{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:20:37Z","timestamp":1789572037793,"version":"build-2803163510"},"reference-count":17,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Biomedical Research Institute Grant","award":["20240064"],"award-info":[{"award-number":["20240064"]}]},{"DOI":"10.13039\/501100008130","name":"Pusan National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Soonchunhyang University Research Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The current American Thyroid Association (ATA) guidelines recommend tailored TSH suppression, considering the recurrence risk of differentiated thyroid cancer (DTC); however, the evidence is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This meta-analysis aimed to investigate the risk of recurrence in patients with DTC, stratified by the ATA risk of recurrence, according to variable thyrotropin (TSH) cutoffs (0.1, 0.5, and 2.0 mIU\/L).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched Ovid-Medline, EMBASE, and Cochrane databases for studies reporting the recurrence rate of DTCs based on TSH cutoffs through March 2024. The search terms used included \u201cthyroid neoplasm\u201d OR \u201ccancer,\u201d \u201cTSH\u201d OR \u201cthyroid stimulating hormone,\u201d \u201csuppress\u201d OR \u201csupplementation,\u201d and \u201cthyroidectomy\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two randomized controlled trials and 7 observational studies, including 5320 patients, were analyzed, with an overall recurrence rate of 18%. The pooled recurrence risk for DTCs at each TSH cutoff (0.1, 0.5, and 2.0 mIU\/L) was not significant. In the subgroup analysis, the pooled hazard ratios (HRs) stratified by the ATA risk of recurrence (low- and high-risk DTCs) did not differ according to TSH levels. However, the risks of recurrence increased at serum TSH of 0.1 mIU\/L or greater (HR 2.27; 95% CI, 1.29-3.99) and TSH of 2.0 mIU\/L or greater (HR 1.36; 95% CI, 1.001-1.84) in a leave-one-out meta-analysis after removing the study that significantly influenced the analysis. Patients with distant metastases had a higher risk of recurrence (HR 3.3; 95% CI, 1.53-7.10) when maintaining a TSH greater than or equal to 0.1 mIU\/L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The degree of TSH suppression did not affect the overall risk of DTC recurrence. However, TSH suppression may be beneficial in reducing the recurrence risk in high-risk patients with distant metastases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf463","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T11:47:01Z","timestamp":1755085621000},"page":"3588-3598","source":"Crossref","is-referenced-by-count":9,"title":["TSH Cutoffs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4599-2889","authenticated-orcid":false,"given":"Yoon Young","family":"Cho","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Soonchunhyang University Bucheon Hospital , Bucheon 14584 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyun","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Ajou University , Suwon 16499 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital , Busan 49241 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-0873","authenticated-orcid":false,"given":"Eun Kyung","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Thyroid Cancer, National Cancer Center , Goyang 10408 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-6364","authenticated-orcid":false,"given":"Young Joo","family":"Park","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute, Medical Research Center, Seoul National University , Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul 03080 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dughyun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Soonchunhyang University Bucheon Hospital , Bucheon 14584 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Soonchunhyang University Bucheon Hospital , Bucheon 14584 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Hee","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Soonchunhyang University Bucheon Hospital , Bucheon 14584 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Oh","family":"Mok","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Soonchunhyang University Bucheon Hospital , Bucheon 14584 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Soonchunhyang University Bucheon Hospital , Bucheon 14584 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-9457","authenticated-orcid":false,"given":"Bo Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital , Busan 49241 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"4","key":"2025111718530313200_dgaf463-B1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2025111718530313200_dgaf463-B2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/thy.2021.0662","article-title":"Thyroid cancer incidence and mortality trends in the United States: 2000-2018","volume":"32","author":"Megwalu","year":"2022","journal-title":"Thyroid"},{"issue":"1","key":"2025111718530313200_dgaf463-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"12","key":"2025111718530313200_dgaf463-B4","first-page":"4318","article-title":"Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer","volume":"81","author":"Pujol","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025111718530313200_dgaf463-B5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1530\/eje.0.1410460","article-title":"Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma","volume":"141","author":"B\u00f6hm","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025111718530313200_dgaf463-B6","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1210\/jc.2010-0161","article-title":"Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial","volume":"95","author":"Sugitani","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025111718530313200_dgaf463-B7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/thy.2014.0287","article-title":"Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma","volume":"25","author":"Wang","year":"2015","journal-title":"Thyroid"},{"issue":"2","key":"2025111718530313200_dgaf463-B8","doi-asserted-by":"crossref","first-page":"e187754","DOI":"10.1001\/jamanetworkopen.2018.7754","article-title":"Association of thyrotropin suppression with survival outcomes in patients with intermediate- and high-risk differentiated thyroid cancer","volume":"2","author":"Klubo-Gwiezdzinska","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2025111718530313200_dgaf463-B9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4158\/EP-2018-0393","article-title":"Is it worth suppressing TSH in low- and intermediate-risk papillary thyroid cancer patients before the first disease assessment?","volume":"25","author":"Lamartina","year":"2019","journal-title":"Endocr Pract"},{"issue":"6","key":"2025111718530313200_dgaf463-B10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1089\/thy.2023.0711","article-title":"The effect of thyrotropin suppression on survival outcomes in patients with differentiated thyroid cancer: a systematic review and meta-analysis","volume":"34","author":"Gubbi","year":"2024","journal-title":"Thyroid"},{"issue":"7","key":"2025111718530313200_dgaf463-B11","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"9","key":"2025111718530313200_dgaf463-B12","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1210\/JC.2015-1346","article-title":"Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987-2012","volume":"100","author":"Carhill","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025111718530313200_dgaf463-B13","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1530\/ERC-17-0453","article-title":"8th edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2)","volume":"25","author":"Lamartina","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"2025111718530313200_dgaf463-B14","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1210\/jc.2006-2566","article-title":"Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer","volume":"92","author":"Hovens","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025111718530313200_dgaf463-B15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1515\/fco-2015-0010","article-title":"The efficacy of thyrotropin suppression therapy in treatment of differentiated thyroid cancer after total thyroidectomy","volume":"6","author":"Abo-Touk","year":"2015","journal-title":"Forum Clin Oncol"},{"issue":"6","key":"2025111718530313200_dgaf463-B16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/cancers14061470","article-title":"Is maintaining thyroid-stimulating hormone effective in patients undergoing thyroid lobectomy for low-risk differentiated thyroid cancer? A systematic review and meta-analysis","volume":"14","author":"Won","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2025111718530313200_dgaf463-B17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/thy.2024.0330","article-title":"Association between serum thyrotropin and cancer recurrence in differentiated thyroid cancer: a population-based retrospective cohort study","volume":"35","author":"Qiang","year":"2025","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf463\/64046266\/dgaf463.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/12\/3588\/64046266\/dgaf463.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/12\/3588\/64046266\/dgaf463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:53:24Z","timestamp":1763423604000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/12\/3588\/8234540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,8,14]]},"published-print":{"date-parts":[[2025,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf463","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,14]]}}}